Therapeutic potential of the latest oxygen affinity‐modifying agent, GBT021601 , for treating sickle cell disease is questionable is a research paper published in British Journal of Haematology (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
National Heart, Lung, and Blood Institute, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
FWCI
0.87
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords